INTUITIVE SURGICAL INC — Form 8-K
Filed July 16, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 42/100
What the filing says
Intuitive reported Q2 2026 revenue of $2.89 billion (+19% YoY), driven by worldwide procedure growth of ~16% (da Vinci +15%, Ion +36%). Da Vinci placements increased to 468 systems (vs. 395 YoY); Ion placements were 55 (vs. 54 YoY). GAAP net income was $818 million or $2.29/diluted share; non-GAAP net income was $1.00 billion or $2.80/share. The company guided 2026 da Vinci procedure growth of 13.5%–15.5% and non-GAAP gross margin of 68%–69%, citing tariff headwinds of ~1% of revenue.
Why this rating
Strong organic growth (16–19%) and margin expansion are constructive; however, tariff risk and guidance moderation (13.5–15.5% vs. achieved 15%) suggest headwinds ahead. Relative to $194B market cap, this is solid quarterly performance but not transformational.
See more from July 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.